How biopharma is girding for climate change – via @StatNews

Takeda predicts that climate change will help its Zika and dengue fever vaccines find a larger market. Roche says it could ultimately make it attractive for the company to develop treatments for diseases like malaria. And AbbVie says extreme weather events might boost its immunology products.

Source: How biopharma is girding for climate change – STAT